some shorters might still think PNV is overpriced
its got a market cap of 950 million and revenues of 44 million (23x annual revenue)
how does that valuation stack up to other healthcare companies on the asx?
if they think PNV shareprice is overpriced and will fall they could short the stock now. but to do so they need to be able to borrow the shares
some fund managers now in certain countries require the company lending them to declare the purpose of their lending ie if they are shorting the stock in an attempt to improve transparency in the market
some shorters might still think PNV is overpricedits got a...
-
- There are more pages in this discussion • 3,077 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |